Member Info for lordloadsoflolly

Reserved - not sure your PE ratios have taken into account the costs to generate that estimated $4m per well p.a?

Can't recall Bo ever putting an exact figure on it. But I know he said margins were high & believe he implied roughly deduct $1m cost per $4m revenue generated? In which case your estimates might be a bit toppy (also assuming those PE ratios are fair).

But I agree, the SP seems unduly mean right now & I suspect that'll change once production starts & the first offtake agreement has been announced.

Morri940 - all very well saying Tim's a deal maker.

Perhaps you could name all the deals he's successfully got over the line?

CaptainJack - I've done the same. But it's obviously a risk until Inez #1 flow testing results are known.

I guess that's what's keeping the SP in check currently.

VikR - you may be right. You may not.

Fact remains your "evidence based research" is nothing of the sort.

It's purely what you've picked up from IMM's own employees (hardly unbiased) & what's allegedlyhappened to all your "other similar scientific shares/biotech holdings" (which are hardly representative of IMM, assuming they even exist).

I suggest you do a bit more research into Tim McCarthy's track record on delivery versus hype. Try starting with Incanthera. Then try telling us you still stand by your evidence based research.

VikR - suggest you stop presenting opinion as fact.

You’ve NO idea whether “The bottom is set in and the only way now is up. Miss it miss out and buy it a higher price with fewer shares”.

CaptainJack - yup. 25th July RNS stated "Workover rig mobilisation and flow testing to commence in early August 2025".

Maybe they've brought things forward?

VikR - “Now how that is elucidated to make it therapeutically potent and commercially viable is where we stagnate”.

Unfortunately that’s the only thing that matters to both investors & patients.

Not some YouTube video with the theory.

VikR - “That’s my scientific assessment based on the info”.

SCIENTIFIC? My rrrrrs.

All you’ve done is take Tim’s words on trust. Which is about as far from scientific as you could possibly get.

Gallini - the one thing almost 40 years of investing has taught me is to ignore broker price targets.

Whilst DB may be right, at the end of the day they know nothing more than the rest of us. Personally, I think Tesco’s re-rate this year may soon run out of steam.

Sadly, when it comes to DIY, I've never been able to muster much "old fashioned patience".

Swearing, though, I can do.

Bazza - well I guess it might be worth it for anyone wanting a bit of lightweight fiction for their summer hols.

Bazzaman - gotta laugh at that latest Investor Report.

]

Reading it, anyone would think TEK was doing well & that its shareholders were reaping massive rewards.

Yet here we are with TEK's SP currently in constant decline. And no sign whatsoever of any payout:

"we seek to provide shareholders with special dividends concomitant with material monetisations of our portfolio."

YEAH RIGHT. Gross-Lee-Incompetent's been telling us that for YEARS now. Anyone who still buys his nonsense should take a long hard look at the facts.

Span -- agreed.

Rollout timetable is an unknown. Being Hex, they won’t hang around, but it will be gradual & controlled.

My guess is extraction from the initial 5 wells will be up to full speed by this calendar year end. But that is just a guess.

Laura - Tim will have known about the need for patent protection long before all his interviews promising a ground-breaking deal & positive left field surprises.

So your argument simply doesn’t stack up I’m afraid. Good luck with any purchases you actually make. I fear you’re gonna need it.

Skid - it’s not just that link that refers specifically to gross revenue. As I said before, Google the term & you’ll find pages of references to it.

But it appears 35 years of being a “qualified accountant” has closed your mind to anything that happens not to support your narrow personal beliefs.

No point in arguing any further with you on this. Filtered.

Skid - I did read it & I’m afraid it simply shows you’re wrong.

If you don’t believe me, just Google whether gross revenue’s a thing. You’ll soon discover it is.

I made no reference to Opti’s RNS - just said gross revenue was a valid accounting term.

DropD - like Kaeren said!

Sure, they've been going flat out - and they've generally hit all their milestones.

But in their 15th July RNS they also expressed "a preference for a soft-start configuration to reduce fuel usage and improve control during initial startup".

Whilst Hex will undoubtedly move faster than most / all? of its competitors, it'll also adopt a controlled approach to minimise the risk of any stuff ups / unnecessary cost overruns. Which inevitably means taking a bit of extra care & time.

Skid35 - 'fraid you're wrong on that. There IS such a thing as gross revenue:

www.accountingfirms.co.uk/blog/gross-revenue-vs-net-revenue/

The one thing I still think's very hard to predict is $/mcf.

$500 may be highly conservative once a predictable, high volume source is fully operational. But it might be worth a lot less than that in the early stages when the volume won't be there in the same way, since supply will only gradually build up.

I'm still very positive on Hex's short to medium term prospects, but I see this potentially being a slightly more gradual winner (over the next 12-18 months), rather than an "overnight" bagger.

AquarianAge - agreed. I'll continue my strategy here of top-slicing small amounts, then buying back in if there's a 10%+ SP correction.

Most of my holding's in ISA format, so no CGT issue. But I'm gradually whittling down the non-ISA part. Gonna take forever, given my average buy in price was 322p & CGT allowance only stretches to £3k annually (probs less by the time Rachel from Accounts is done with us).